维普中文期刊产品整合服务
384篇 您的检索式:作者名="Anderson WF"
    题名 作者 年代 出处 被引量
1Retroviral vector mediated gene transfer of antisense cyclin G1 ( CYC G1 ) inhibits proliferation of human osteogenic sarcoma cells显示文摘Skotzko M Wu L Anderson WF 1995Cancer Res1995,55,23:1
2Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemi- ology, and end results program at the National Cancer Institute 显示文摘Hance KW Anderson WF Devesa SS 2005J Natl Cancer Inst2005,97,13:1
3Patterns of cancer inci-dence,mortality,and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world显示文摘Kamangar F Dores GM Anderson WF 0,,:1
4Patterns of cancer incidence,mortality,and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world显示文摘Kamangar F Dores GM Anderson WF 2006J Clin Oncol2006,24,14:1
5Safety issues related to retrovial-mediated gene transfer in hunman显示文摘Conmetta K Morgan RA Anderson WF 1991Human Gene Ther1991,2,:1
6Global trends in breast cancer incidence and mortality 1973-1997显示文摘Althuis MD Doffer JM Anderson WF 2005Int J Epidemi- ol2005,34,2:1
7Globaltrends in breast cancer incidence and mortality 1973~1997显示文摘 DozierJM Anderson WF 2005Int J Epidemiol2005,34,:1
8Patterns of cancer incidence,mortality,and prevalence across five conti-nents:defining priorities to reduce cancer disparities in different geographic regions of the world显示文摘Kamangar F Dores GM Anderson WF 2006J Clin Oncol2006,24,14:1
9World- wide Trends in incidence rates for oral cavity and oropharyngeal cancers显示文摘Chaturvedi AK Anderson WF Lortet-Tieulent J st al 2013J Clin Oncol2013,31,36:1
10Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma:distinct clinicopathologic entities显示文摘Anderson WF Chu KC Chang S 0,,12:1
11Increasing breast cancer incidence in China:the numbers add up显示文摘ZIEGLER RG ANDERSON WF GAIL MH 0,,19:1
12The major genetic determinants of HIV-1control affect HLA class I peptide presentation显示文摘International HIV Controllers Study Pereyra F Jia X McLaren P J Telenti A de Bakker P I Walker B D Ripke S Brumme C J Pulit S L Carrington M Kadie C M Carlson J M Heckerman D Graham R R Plenge R M Deeks S G Gianniny L Crawford G Sullivan J Gonzalez E Davies L Camargo A Moore JM Beattie N Gupta S Crenshaw A Burtt N P Guiducci C Gupta N Gao X Qi Y Yuki Y Piechocka-Trocha A Cutrell E Rosenberg R Moss K L Lemay P O'Leary J Schaefer T Verma P Toth I Block B Baker B Rothchild A Lian J Proudfoot J Alvino D M Vine S Addo M M Allen T M Altfeld M Henn M R Le Gall S Streeck H Haas D W Kuritzkes D R Robbins G K Shafer R W Gulick R M Shikuma C M Haubrich R Riddler S Sax P E Daar E S Ribaudo H J Agan B Agarwal S Ahern R L Allen B L Altidor S Altschuler E L Ambardar S Anastos K Anderson B Anderson V Andrady U Antoniskis D Bangsberg D Barbaro D Barrie W Bartczak J Barton S Basden P Basgoz N Bazner S Bellos N C Benson A M Berger J Bernard N F Bernard A M Birch C Bodner S J Bolan R K Boudreaux E T Bradley M Braun J F Brndjar J E Brown S J Brown K Brown S T Burack J Bush LM Cafaro V Campbell O Campbell J Carlson R H Carmichael J K Casey K K Cavacuiti C Celestin G Chambers S T Chez N Chirch L M Cimoch P J Cohen D Cohn LE Conway B Cooper D A Cornelson B Cox D T Cristofano M V Cuchural G Jr Czartoski J L Dahman J M Daly J S Davis B T Davis K Davod S M DeJesus E Dietz C A Dunham E Dunn M E Ellerin T B Eron J J Fangman J J Farel C E Ferlazzo H Fidler S Fleenor-Ford A Frankel R Freedberg K A French N K Fuchs JD Fuller J D Gaberman J Gallant J E Gandhi R T Garcia E Garmon D Gathe J C Jr Gaultier C R Gebre W Gilman F D Gilson I Goepfert P A Gottlieb M S Goulston C Groger R K Gurley T D Haber S Hardwicke R Hardy W D Harrigan P R Hawkins T N Heath S Hecht F M Henry W K Hladek M Hoffman R P Horton J M Hsu R K Huhn G D Hunt P Hupert M J Illeman M L Jaeger H Jellinger R M John M Johnson J A Johnson K L Johnson H Johnson K Joly J Jordan W C Kauffman C A Khanlou H Killian R K Kim A Y Kim D D Kinder C A Kirchner J T Kogelman L Kojic E M Korthuis P T Kurisu W Kwon D S LaMar M Lampiris H Lanzafame M Lederman M M Lee D M Lee J M Lee M J Lee E T Lemoine J Levy J A Llibre J M Liguori M A Little S J Liu A Y Lopez A J Loutfy M R Loy D Mohammed D Y Man A Mansour M K Marconi V C Markowitz M Marques R Martin J N Martin H L Jr Mayer K H McElrath M J McGhee T A McGovern B H McGowan K McIntyre D Mcleod GX Menezes P Mesa G Metroka CE Meyer-Olson D Miller A O Montgomery K Mounzer K C Nagami E H Nagin I Nahass R G Nelson M O Nielsen C Norene D L O'Connor D H Ojikutu B O Okulicz J Oladehin O O Oldfield E C Olender S A Ostrowski M Owen WF Jr Pae E Parsonnet J Pavlatos A M Perlmutter A M Pierce M N Pincus J M Pisani L Price L J Proia L Prokesch R C Pujet H C Ramgopal M Rathod A Rausch M Ravishankar J Rhame F S Richards C S Richman D D Rodes B Rodriguez M Rose R C 3rd Rosenberg E S Rosenthal D Ross P E Rubin D S Rumbaugh E Saenz L Salvaggio M R Sanchez WC Sanjana V M Santiago S Schmidt W Schuitemaker H Sestak P M Shalit P Shay W Shirvani V N Silebi V I Sizemore J M Jr Skolnik P R Sokol-Anderson M Sosman J M Stabile P Stapleton J T Starrett S Stein F Stellbrink H J Sterman FL Stone V E Stone D R Tambussi G Taplitz R A Tedaldi E M Telenti A Theisen W Torres R Tosiello L Tremblay C Tribble M A Trinh P D Tsao A Ueda P Vaccaro A Valadas E Vanig T J Vecino I Vega V M Veikley W Wade B H Walworth C Wanidworanun C Ward D J Warner D A Weber R D Webster D Weis S Wheeler D A White D J Wilkins E Winston A Wlodaver C G van't Wout A Wright D P Yang O O Yurdin D L Zabukovic B W Zachary K C Zeeman B Zhao M 2010Science2010,330,6010:1
13Patterns of cancer in-cidence,mortality,and prevalence across five continents ; defining priorities to reduce cancer disparities in different geographic regions of the world显示文摘Kamangar F Dores GM Anderson WF 2006J Clin Oncol2006,24,14:1
14The ADA human gene therapy clinical protocol:points to consider response with clinical protocol 显示文摘Anderson WF Blaese RM Culver K 1990Hum Gene Ther1990,1,3:1
15Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer 显示文摘Hess RK Anderson K Symmans WF 2006J Gin Oncol2006,24,26:1
16Globaltrends in breast cancer incidence and mortality 1973-1997 显示文摘Althuis MD DozierJD Anderson WF 2005Int J Epidemiol2005,34,2:1
17Is male breast cancer similar or different than female breast cancer 显示文摘Anderson WF Althuis MD Brinton LA 2004Breast Cancer Res Treat2004,83,1:1
18The ADA human gene therapy elinical protocol: points to consider response with clinical protocol显示文摘Anderson WF Blaese RM Culver K etal 1990Hum Gene Ther1990,1,3:1
19Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles显示文摘Anderson SA Rader RK Westlin WF 2000Magn Reson Med2000,44,3:1
20The use of X-ray computer topography to investigate particulate interactions within opencast coal mine backfills显示文摘Goodwin AK O'Nell MA Anderson WF 2003Engineering Geology2003,70,:1
返回顶部 每页显示:
共20页 首页 上一页 第1页 下一页 末页 /20 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费